Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer.

Bohanes P, Courvoisier DS, Perneger TV, Morel P, Huber O, Roth AD.

Swiss Med Wkly. 2011 Aug 26;141:w13249. doi: 10.4414/smw.2011.13249.

2.

Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens.

Massacesi C, Pistilli B, Valeri M, Lippe P, Rocchi MB, Cellerino R, Piga A.

Am J Clin Oncol. 2002 Apr;25(2):140-8.

PMID:
11943891
3.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M; Italian Oncology Group for Cancer Research, Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R.

J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11.

PMID:
18334706
4.

Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.

Kim JG, Ryoo BY, Park YH, Kim BS, Kim TY, Im YH, Kang YK.

Cancer Chemother Pharmacol. 2008 Feb;61(2):301-7. Epub 2007 Apr 12.

PMID:
17429626
5.

Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?

Kim ST, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH.

Asia Pac J Clin Oncol. 2012 Jun;8(2):194-200. doi: 10.1111/j.1743-7563.2011.01501.x. Epub 2012 Mar 12.

PMID:
22524579
6.

CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.

Pectasides D, Mylonakis A, Kostopoulou M, Papadopoulou M, Triantafillis D, Varthalitis J, Dimitriades M, Athanassiou A.

Am J Clin Oncol. 1997 Aug;20(4):348-53.

PMID:
9256887
7.

Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.

Persiani R, D'Ugo D, Rausei S, Sermoneta D, Barone C, Pozzo C, Ricci R, La Torre G, Picciocchi A.

J Surg Oncol. 2005 Mar 15;89(4):227-36; discussion 237-8.

PMID:
15726615
8.

Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.

Shi C, Yang B, Chen Q, Yang J, Fan N.

Oncology. 2011;80(5-6):289-95. doi: 10.1159/000329075. Epub 2011 Jul 18.

PMID:
21778768
9.

Optimal indications for second-line chemotherapy in advanced gastric cancer.

Hasegawa H, Fujitani K, Nakazuru S, Hirao M, Mita E, Tsujinaka T.

Anticancer Drugs. 2012 Apr;23(4):465-70. doi: 10.1097/CAD.0b013e3283504442.

PMID:
22227714
10.

A systematic overview of chemotherapy effects in breast cancer.

Bergh J, Jönsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):253-81. Review.

PMID:
11441936
11.

Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.

Yoshida M, Ohtsu A, Boku N, Miyata Y, Shirao K, Shimada Y, Hyodo I, Koizumi W, Kurihara M, Yoshida S, Yamamoto S.

Jpn J Clin Oncol. 2004 Nov;34(11):654-9.

PMID:
15613554
12.

The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival.

Tas F, Aykan NF, Aydiner A, Uygun K, Basaran M, Camlica H, Topuz E.

Am J Clin Oncol. 2000 Feb;23(1):53-7.

PMID:
10683078
13.

[The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].

Sugimoto N, Narahara H, Sakai D, Yamamoto S, Fumoto S, Yagi T, Imamura F, Iishi H, Tatsuta M.

Gan To Kagaku Ryoho. 2009 Mar;36(3):417-24. Japanese.

PMID:
19295265
14.

Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen).

Louvet C, Carrat F, Mal F, Mabro M, Beerblock K, Vaillant JC, Cady J, André T, Gamelin E, de Gramont A.

Cancer Invest. 2003;21(1):14-20.

PMID:
12643005
15.

Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.

Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM.

Jpn J Clin Oncol. 2000 Jan;30(1):12-6.

PMID:
10770562
16.

Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.

Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Fujii S, Otsuka Y, Akiyama H, Ono HA, Kosaka T, Ichikawa Y, Shimada H.

Anticancer Res. 2008 Mar-Apr;28(2B):1309-15.

17.

Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.

Yano M, Shiozaki H, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Tsujinaka T, Monden M.

World J Surg. 2002 Sep;26(9):1155-9. Epub 2002 Jun 24.

PMID:
12209246
18.

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI.

Am J Clin Oncol. 1999 Jun;22(3):253-7.

PMID:
10362331
19.

A systematic overview of chemotherapy effects in gastric cancer.

Janunger KG, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):309-26. Review.

PMID:
11441938
20.

Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.

Kim ST, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH.

Oncology. 2010;79(5-6):363-9. doi: 10.1159/000322498. Epub 2011 Mar 24.

PMID:
21430405

Supplemental Content

Support Center